A Study of MP-101 in Dementia-Related Psychosis and/or Agitation and Aggression
Phase 2
Terminated
- Conditions
- PsychosisDementiaAggressionAgitationAlzheimer Dementia
- Interventions
- Drug: Placebo
- First Posted Date
- 2017-02-06
- Last Posted Date
- 2021-04-01
- Lead Sponsor
- Mediti Pharma Inc.
- Target Recruit Count
- 81
- Registration Number
- NCT03044249
- Locations
- 🇨🇦
SKDS Research Inc., Newmarket, Ontario, Canada
🇨🇦Centre de recherche sur le vieillissement du CIUSSS de l'Estrie - CHUS, Sherbrooke, Quebec, Canada
🇺🇸Galiz Research, Miami Springs, Florida, United States
© Copyright 2025. All Rights Reserved by MedPath